Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E2LU
|
||||
| Former ID |
DNC007110
|
||||
| Drug Name |
NSC-275420
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528457] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H13N3O2
|
||||
| Canonical SMILES |
CN1C2=CC(=O)C=CC2=C3C1=C(C=C4C3=NC5=CC=CC=C5N4)O.Cl
|
||||
| InChI |
1S/C19H13N3O2.ClH/c1-22-15-8-10(23)6-7-11(15)17-18-14(9-16(24)19(17)22)20-12-4-2-3-5-13(12)21-18;/h2-9,20,24H,1H3;1H
|
||||
| InChIKey |
AZXHHHFIKRNMAT-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NAD(P)H dehydrogenase [quinone] 1 | Target Info | Inhibitor | [528457] | |
| KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | Validated transcriptional targets of TAp63 isoforms | ||||
| PathWhiz Pathway | Vitamin K Metabolism | ||||
| WikiPathways | Estrogen metabolism | ||||
| Oxidative Stress | |||||
| Transcriptional activation by NRF2 | |||||
| NRF2 pathway | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Aryl Hydrocarbon Receptor Pathway | |||||
| Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
| Metabolism of amino acids and derivatives | |||||
| Aryl Hydrocarbon Receptor | |||||
| Dopamine metabolism | |||||
| Arylhydrocarbon receptor (AhR) signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.